James W. Chu

3.1k total citations · 1 hit paper
27 papers, 2.0k citations indexed

About

James W. Chu is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, James W. Chu has authored 27 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in James W. Chu's work include Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Diabetes Treatment and Management (7 papers) and Metabolism, Diabetes, and Cancer (4 papers). James W. Chu is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Diabetes Treatment and Management (7 papers) and Metabolism, Diabetes, and Cancer (4 papers). James W. Chu collaborates with scholars based in United States, Australia and Taiwan. James W. Chu's co-authors include Gerald M. Reaven, Fahim Abbasi, Tracey McLaughlin, Cindy Lamendola, Karen Cheal, Lawrence M. Crapo, Peter D. Reaven, John L. Faul, Ramona L. Doyle and Peter N. Kao and has published in prestigious journals such as Annals of Internal Medicine, Journal of the American College of Cardiology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

James W. Chu

25 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant

2003 779 citations Tracey McLaughlin, Fahim Abbasi et al. Annals of Internal Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James W. Chu United States	14	1.1k	525	427	369	343	27	2.0k
Chan‐Hee Jung South Korea	31	989 0.9×	562 1.1×	348 0.8×	493 1.3×	428 1.2×	104	2.4k
Kap Bum Huh South Korea	26	1.1k 1.0×	940 1.8×	461 1.1×	459 1.2×	356 1.0×	119	2.4k
Jing Hong China	25	885 0.8×	519 1.0×	429 1.0×	463 1.3×	255 0.7×	104	2.0k
Theodora Temelkova‐Kurktschiev Germany	22	1.3k 1.2×	394 0.8×	541 1.3×	351 1.0×	262 0.8×	47	2.1k
Stephen J. Cleland United Kingdom	22	785 0.7×	369 0.7×	447 1.0×	477 1.3×	336 1.0×	37	1.7k
Shuhei Nakanishi Japan	26	886 0.8×	607 1.2×	288 0.7×	460 1.2×	473 1.4×	132	1.9k
Emanuela Orsi Italy	33	1.7k 1.6×	604 1.2×	452 1.1×	305 0.8×	471 1.4×	94	3.1k
Annaswamy Raji United States	18	994 0.9×	418 0.8×	326 0.8×	339 0.9×	277 0.8×	34	1.7k
Rochelle L Chaiken United States	21	969 0.9×	473 0.9×	278 0.7×	477 1.3×	418 1.2×	28	1.8k
Ginger Hook United States	13	793 0.7×	441 0.8×	1.0k 2.4×	670 1.8×	291 0.8×	15	2.5k

Countries citing papers authored by James W. Chu

Since Specialization

Citations

This map shows the geographic impact of James W. Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James W. Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James W. Chu more than expected).

Fields of papers citing papers by James W. Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James W. Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James W. Chu. The network helps show where James W. Chu may publish in the future.

Co-authorship network of co-authors of James W. Chu

This figure shows the co-authorship network connecting the top 25 collaborators of James W. Chu. A scholar is included among the top collaborators of James W. Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James W. Chu. James W. Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Manser, Renée, James W. Chu, Robert A. Cox, et al.. (2020). Adverse respiratory outcomes following conventional long‐course radiotherapy for non‐small‐cell lung cancer in patients with pre‐existing pulmonary fibrosis: A comparative retrospective study. Journal of Medical Imaging and Radiation Oncology. 64(4). 546–555. 3 indexed citations

Chu, Winston & James W. Chu. (2020). SUN-391 Denosumab Treatment of Patients with Osteoporosis and Idiopathic Hypercalciuria. Journal of the Endocrine Society. 4(Supplement_1).

Grabner, Michael, et al.. (2013). Clinical and Economic Outcomes Among Patients With Diabetes Mellitus Initiating Insulin Glargine Pen Versus Vial. Postgraduate Medicine. 125(3). 204–213. 31 indexed citations

Li, Phoebe, et al.. (2005). Glucose-Lowering Effects of Sulfasalazine in Type 2 Diabetes. Diabetes Care. 28(9). 2238–2239. 13 indexed citations

Lamendola, Cindy, Fahim Abbasi, James W. Chu, et al.. (2005). Comparative effects of rosuvastatin and gemfibrozil on glucose, insulin, and lipid metabolism in insulin-resistant, nondiabetic patients with combined dyslipidemia. The American Journal of Cardiology. 95(2). 189–193. 37 indexed citations

Chu, James W., Fahim Abbasi, Cynthia Lamendola, et al.. (2005). Effect of rosiglitazone treatment on circulating vascular and inflammatory markers in insulin-resistant subjects. Diabetes and Vascular Disease Research. 2(1). 37–41. 35 indexed citations

Abbasi, Fahim, James W. Chu, Theodore P. Ciaraldi, et al.. (2005). Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 290(1). R139–R144. 65 indexed citations

Witteles, Ronald, et al.. (2004). Insulin resistance in idiopathic dilated cardiomyopathy. Journal of the American College of Cardiology. 44(1). 78–81. 94 indexed citations

Abbasi, Fahim, James W. Chu, Tracey McLaughlin, et al.. (2004). Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus. Metabolism. 53(2). 159–164. 130 indexed citations

10.

Beatty, George, James W. Chu, Krishnaji Kulkarni, et al.. (2004). Relative Effects of Insulin Resistance and Protease Inhibitor Treatment on Lipid and Lipoprotein Metabolism in HIV-Infected Patients. HIV Clinical Trials. 5(6). 383–391. 2 indexed citations

11.

Abbasi, Fahim, James W. Chu, Cindy Lamendola, et al.. (2004). 1084-172 Rosuvastatin is efficacious as monotherapy in patients with combined dyslipidemia. Journal of the American College of Cardiology. 43(5). A480–A480. 1 indexed citations

12.

Beatty, George, Mandana Khalili, Fahim Abbasi, et al.. (2003). Quantification of Insulin-Mediated Glucose Disposal in HIV-Infected Individuals: Comparison of Patients Treated and Untreated With Protease Inhibitors. JAIDS Journal of Acquired Immune Deficiency Syndromes. 33(1). 34–40. 12 indexed citations

13.

Chu, James W., Fahim Abbasi, George Beatty, et al.. (2003). Methods for quantifying insulin resistance in human immunodeficiency virus-positive patients. Metabolism. 52(7). 858–861. 12 indexed citations

14.

McLaughlin, Tracey, Fahim Abbasi, Karen Cheal, et al.. (2003). Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant. Annals of Internal Medicine. 139(10). 802–809. 779 indexed citations breakdown →

15.

Chu, James W., Fahim Abbasi, Tracey McLaughlin, et al.. (2003). Lipoprotein risk factors for cardiovascular disease in patients with type 2 diabetes mellitus treated with oral antihyperglycaemic agents. Diabetes Obesity and Metabolism. 5(5). 333–337. 1 indexed citations

16.

Witteles, Ronald, et al.. (2002). High prevalence of impaired glucose metabolism in patients with idiopathic dilated cardiomyopathy. Journal of the American College of Cardiology. 39. 181–181. 1 indexed citations

17.

Chu, James W., Peter N. Kao, John L. Faul, & Ramona L. Doyle. (2002). High Prevalence of Autoimmune Thyroid Disease in Pulmonary Arterial Hypertension. CHEST Journal. 122(5). 1668–1673. 127 indexed citations

18.

Wang, Pei-Wen, Chia‐Wei Liou, Shan‐Tair Wang, et al.. (2002). Relative impact of low-density lipoprotein-cholesterol concentration and insulin resistance on carotid wall thickening in nondiabetic, normotensive volunteers. Metabolism. 51(2). 255–259. 12 indexed citations

19.

Chu, James W. & Lawrence M. Crapo. (2001). The Treatment of Subclinical Hypothyroidism Is Seldom Necessary. The Journal of Clinical Endocrinology & Metabolism. 86(10). 4591–4599. 170 indexed citations

20.

Chu, James W., et al.. (1995). Metastatic Thoracic Intramedullary Small Cell Carcinoma: Case Report.. Journal of Korean Neurosurgical Society. 24(7). 826–830.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact